Discovery could enable access to both enantiomers of a drug in a single synthesis
A novel method in which a chiral catalyst forms first one, then later the other enantiomer of a molecule has been developed by chemists in China. The researchers believe it could potentially allow access to both enantiomers of novel pharmaceutical molecules through the same synthesis route.